Pasture Holdings (UUK) Fair Value & Analysis
Healthcare · SG · Market cap 9.9M SGD
Fair value as of: Jul 4, 2026
From 22 valuation models · updated today
Price vs Fair Value (12 months)
12‑month range 0.0510 SGD – 0.1855 SGD · fair‑value band 0.0714 SGD – 0.1018 SGD · the 0.0760 SGD price screens below the 0.0866 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Pasture Holdings (UUK) currently trades at 0.0760 SGD, while our model-based Fair Value estimate is 0.0866 SGD — implying the stock looks roughly 14.0% undervalued today. We read business quality at 54/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Pasture Holdings generated revenue of 9.3M SGD at a net margin of -7.6%. Revenue declined 40.6% year over year. It earns a return on equity of -16.8%. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Pasture Holdings Ltd. operates as a pharmaceutical products and medical supply company in Japan, Hong Kong, Canada, Singapore, and internationally. The company operates through three segments: Pharmaceutical Wholesale and Drop-Shipment; Masks and Medical Supplies; and Other Services. It is involved in the wholesale procurement and transshipment of pharmaceutical and nutraceutical products, such as vaccines and oncology treatments; and backend support of pharmaceutical supplies to international clients' online pharmacy businesses. The company also sells surgical masks, n95 respirators, surgical n95 respirators, and n95 respirators; wound care; urology, incontinence care, and drainage; personal protective equipment; and IV therapy and vascular access. In addition, it offers oral disintegrating strips; and pet pharmaceutical and nutraceutical products and services; and furlife, a mobile application for pets. The company was founded in 1996 and is based in Singapore. Pasture Holdings …
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Pasture Holdings reported revenue of 12.2M SGD in FY2025 versus 15.1M SGD in FY2022, a compound −7.0%/yr. Reported net income was 541K SGD in FY2025, compounding −39.6%/yr from FY2022.
Is UUK fairly valued? → Check now
Similar stocks
6 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation M1CK34 | R$1,022 | R$1,243 | +22% |
| Cencora, Inc C1CO34 | R$709.32 | R$400.70 | -44% |
| Cardinal Health, Inc CAH | $216.30 | $110.75 | -49% |
| Sigma Healthcare Limited SIGGF | $2.35 | $0.7800 | -67% |
| Shanghai Pharmaceuticals Holding 601607 | ¥15.96 | ¥56.73 | +255% |
| Henry Schein, Inc HSIC | $78.67 | $67.77 | -14% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Pasture Holdings (UUK) undervalued?
What is the fair value of UUK?
What is the quality score of UUK?
What is the revenue of Pasture Holdings (UUK)?
What is the net profit margin of UUK?
Does Pasture Holdings pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.